1 study found for:    19289629 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Nilutamide;   Drug: Dasatinib

Indicates status has not been verified in more than two years